Bieke Broux
Overpelt, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Cytomegalovirus Drives the Development of Cytotoxic CD4+ T Cells in Patients With Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 23, 2026
Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.
Autoantigen mRNA-LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 06, 2026
Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis.
Journal: bioRxiv : the preprint server for biology
Published: March 05, 2026
Itolizumab targets the CD6-ALCAM axis to limit T-cell responses and brain barrier diapedesis in multiple sclerosis.
Journal: Journal of autoimmunity
Published: February 14, 2026
Adipose tissue-derived extracellular vesicles as drivers of endothelial dysfunction in obesity.
Journal: Trends in endocrinology and metabolism: TEM
Published: September 12, 2025
Beyond the innate immune system: rethinking inflammasomes in multiple sclerosis.
Journal: Trends in immunology
Published: August 29, 2025
Engineering Peptide Modulators for T-Cell Migration by Structural Scaffold Matching.
Journal: Journal of medicinal chemistry
Published: August 12, 2025
Antigen presentation at the brain barriers in multiple sclerosis.
Journal: Neural regeneration research
Published: February 14, 2025
Effects and mechanisms of adipose tissue-derived extracellular vesicles in vascular inflammation and dysfunction.
Journal: Neural regeneration research
Published: December 19, 2024
Sex differentially affects pro-inflammatory cell subsets in adipose tissue depots in a diet induced obesity model.
Journal: Biology of sex differences
Published: April 07, 2024
Effect on neutrophil migration and antimicrobial functions by the Bruton's tyrosine kinase inhibitors tolebrutinib, evobrutinib, and fenebrutinib.
Journal: Journal of leukocyte biology
Published: February 28, 2024
Last Updated: 09/26/2026